A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2013
11/27/2013	CN102641236B Expandable biological adhesive sustained and controlled release preparation for preventing and curing oral diseases and preparation method thereof
11/27/2013	CN102558298B Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers
11/27/2013	CN102526566B Chinese medicine preparation for treating hysteromyoma and ovaricyst and preparation method
11/27/2013	CN102512656B Quinapril hydrochloride medicinal composition
11/27/2013	CN102512495B Allergic cough oral liquid
11/27/2013	CN102512392B Manidipine hydrochloride solid dispersion, preparation and preparation method of above
11/27/2013	CN102512387B Zalcitabine drug composition
11/27/2013	CN102448427B 组合物 The composition
11/27/2013	CN102440974B Olanzapine orally disintegrating pharmaceutical composition
11/27/2013	CN102429881B Method for preparing benzbromarone tablets
11/27/2013	CN102397384B Heartleaf houttuynia herb eye drops and preparation method thereof
11/27/2013	CN102319394B Xingnaojing composition for injection and preparation method thereof
11/27/2013	CN102228673B Capsules for treating diabetes and preparation method thereof
11/27/2013	CN102107011B Paramagnetic-upconversion luminous composite nanometer particle, preparation method and application thereof
11/27/2013	CN102038645B Desloratadine grain and preparation method thereof
11/27/2013	CN102018852B Ginseng and coptis capsule for quenching thirsty and reducing blood sugar and preparation process
11/27/2013	CN101947205B Novel galanthamine sustained-release preparation and preparation method thereof
11/27/2013	CN101809446B Sol-gel phase-reversible hydrogel templates and uses thereof
11/27/2013	CN101744960B Sangusis draconis notoginseng bone-setting ointment and preparation method thereof
11/27/2013	CN101686714B In situ, liquid-activated film coated tablets and process for making same
11/27/2013	CN101632650B Self-microemulsifying semisolid skeleton capsule of daidzein and preparation method thereof
11/27/2013	CN101579311B 改进的药物递送系统 Improved drug delivery systems
11/27/2013	CN101502492B Method for preparing clarithromycin granule without bitter taste
11/26/2013	US8592490 Self-microemulsifying drug delivery systems
11/26/2013	US8592481 Gastric retentive gabapentin dosage forms and methods for using same
11/26/2013	US8592406 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant
11/26/2013	US8592210 Polyarginine-modified liposome having nuclear entry ability
11/26/2013	US8591955 Orally rapidly disintegrating tablet that contains two or more types of particles
11/26/2013	US8591954 Phospholipid-based inhalation system
11/26/2013	US8591953 Drug carrier and drug carrier kit for inhibiting fibrosis
11/26/2013	US8591952 Absorbant superhydrophobic materials, and methods of preparation and use thereof
11/26/2013	US8591951 Tri-block copolymers for nanosphere-based drug delivery
11/26/2013	US8591950 Hydrogel implants with varying degrees of crosslinking
11/26/2013	US8591948 Antifungal compositions with improved bioavailability
11/26/2013	US8591947 Dual controlled release dosage form
11/26/2013	US8591946 Modified release compositions comprising tacrolimus
11/26/2013	US8591945 Pregelatinized starch in a controlled release formulation
11/26/2013	US8591944 Solid dispersion formulations and methods of use thereof
11/26/2013	US8591943 Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors
11/26/2013	US8591942 Methods for the preparation of liposomes comprising docetaxel
11/26/2013	US8591941 Transdermal drug delivery device including an occlusive backing
11/26/2013	US8591940 Method of treating scar tissue
11/26/2013	US8591935 Methods and compositions for treating pain comprising a statin
11/26/2013	US8591925 Lipophilically surface-treated powder having easy dispersability and cosmetic blended with such a powder
11/26/2013	US8591921 Induction of tumor hypoxia for cancer therapy
11/26/2013	US8591920 Stable lipophilic emulsions for acrylic coating and method of making
11/26/2013	US8591908 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis B and the producing method and use thereof
11/26/2013	US8591897 Anti-ERBB2 antibody adjuvant therapy
11/26/2013	US8591885 Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
11/26/2013	US8591884 Compositions and methods for enhancing metal ion dependent drug therapies
11/26/2013	US8591870 Compositions and methods for treating conditions of the nail unit
11/26/2013	US8591866 Formulations decreasing particle exhalation
11/26/2013	US8591499 Tools and methods for programming an implantable valve
11/26/2013	US8591498 Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
11/26/2013	CA2816216C Binding drugs with nanocrystalline cellulose (ncc)
11/26/2013	CA2738683C Anhydrous antiperspirant compositions
11/26/2013	CA2717984C Enhanced transmucosal composition and dosage form
11/26/2013	CA2685831C Novel pharmaceutical composition
11/26/2013	CA2661892C Gel type enteral nutrient
11/26/2013	CA2643944C Solid dosage form containing a taste masked active agent
11/26/2013	CA2612738C Solid pharmaceutical composition comprising (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman
11/26/2013	CA2608811C Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
11/26/2013	CA2608283C Pharmaceutical compositions with synchronized solubilizer release
11/26/2013	CA2604170C Rechargeable dermal patch
11/26/2013	CA2554051C Non-lamellar compositions of dope and p80
11/26/2013	CA2534132C Medicaments for inhalation comprising betamimetics and an anticholinergic
11/21/2013	WO2013173822A1 Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer
11/21/2013	WO2013173778A1 Methods for treating or predicting risk of a ventricular tachyarrhythmia event
11/21/2013	WO2013173693A1 Nanoparticles with enhanced entry into cancer cells
11/21/2013	WO2013173687A1 High-concentration monoclonal antibody formulations
11/21/2013	WO2013173676A1 Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto
11/21/2013	WO2013173336A1 Easily formulated zinc oxide powder
11/21/2013	WO2013173317A1 TREATMENT OF OBSTRUCTIVE SLEEP APNEA WITH α2-ADRENERGIC RECEPTOR AGONISTS
11/21/2013	WO2013173180A2 Histatin for corneal wound healing and ocular surface disease
11/21/2013	WO2013172805A1 New orodispersible tablet formulations of olanzapine
11/21/2013	WO2013172721A1 Combination treatments and compositions for wound healing
11/21/2013	WO2013172669A1 Method for manufacturing nano-liposome containing nucleic acid without extrusion process
11/21/2013	WO2013172627A1 Mucoadhesive nanoform microparticles
11/21/2013	WO2013172468A1 Sterilized composition
11/21/2013	WO2013172467A1 Radiation-sterilization-resistant protein composition
11/21/2013	WO2013172358A1 Functional compound, molecular assembly containing functional compound, composition containing molecular assembly, kit, and use of molecular assembly, composition or kit
11/21/2013	WO2013172297A1 Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative
11/21/2013	WO2013172292A1 Aqueous gel
11/21/2013	WO2013171766A2 Saxagliptin solid dispersion
11/21/2013	WO2013171763A1 Ready to be infused gemcitabine solution
11/21/2013	WO2013171726A1 Non-ionic vesicle formulations of calcium channel blockers
11/21/2013	WO2013171697A1 Oral composition comprising a low- availability active ingredient, for use as a medicament or a dietary/supplement/nutraceutical
11/21/2013	WO2013171668A1 Liposomes containing prostaglandin e1 (pge1) and a plant oestrogen, formulations for topical use containing them and their use
11/21/2013	WO2013171570A1 Polypeptide loaded poca nanoparticles for oral administration
11/21/2013	WO2013171382A1 Docetaxel-based prolonged-release cancer treatment drug
11/21/2013	WO2013171270A1 Formulation for low bioavailability substances containing a n-acetylcysteine-chitosan salt
11/21/2013	WO2013171252A1 Means to facilitate food intake and food retention
11/21/2013	WO2013171204A2 Ophthalmological vehicle system for medicaments, ophthalmological kit and use of an ophthalmological composition
11/21/2013	WO2013171203A1 Fluid dispenser containing an ophthalmological composition
11/21/2013	WO2013171164A1 Compositions and formulations for the treatment of halitosis
11/21/2013	WO2013171146A1 Oral film containing enteric release opiate resinate
11/21/2013	WO2013171132A1 Vesicular formulations, kits and uses
11/21/2013	WO2013171131A1 Vesicular formulations, uses and methods
11/21/2013	WO2013170921A1 Combination therapy agent for treating rhinitis
11/21/2013	WO2013170317A1 Liquid formulation

1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 2991